A Phase II, Multi-centre Study, of Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases From Non-small Cell Lung Cancer and Renal Cell Cancer
Phase of Trial: Phase II
Latest Information Update: 10 Aug 2017
At a glance
- Drugs Nivolumab (Primary)
- Indications Brain metastases; Non-small cell lung cancer; Renal cell carcinoma
- Focus Therapeutic Use
- 10 Jul 2017 Planned primary completion date changed from 1 Feb 2020 to 1 Jun 2020.
- 10 Jul 2017 Status changed from not yet recruiting to recruiting.
- 06 Dec 2016 New trial record